Form 4 for LH Labcorp
Accepted 2023-04-03 00:00:00 ET · period of report 2023-03-30 · accession 0001127602-23-011748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-03 | 2023-03-30 | LH | Caveney Brian J | EVP, Pres of Diagnostics | F - Tax | $224.70 | -2,990 | 20.2K | -13% | -$671.9K | |
| 2023-04-03 | 2023-03-30 | LH | Caveney Brian J | EVP, Pres of Diagnostics | A - Grant | $0.00 | +6,763 | 23.2K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-30 | F | D | 2,990 | $224.70 | 20,185.76 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-30 | A | A | 6,763 | $0.00 | 23,175.76 | D | — | — |